Two Sigma Investments’s Taysha Gene Therapies TSHA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.32M Buy
742,081
+390,955
+111% +$1.82M ﹤0.01% 2360
2025
Q4
$1.93M Buy
351,126
+285,021
+431% +$1.38M ﹤0.01% 2464
2025
Q3
$216K Buy
66,105
+33,423
+102% +$94.6K ﹤0.01% 3351
2025
Q2
$75.5K Buy
+32,682
New +$71K ﹤0.01% 3029
2025
Q1
Sell
-12,300
Closed -$21.3K 3497
2024
Q4
$21.3K Buy
+12,300
New +$25.5K ﹤0.01% 3102
2024
Q2
Sell
-121,517
Closed -$349K 3336
2024
Q1
$349K Sell
121,517
-15,456
-11% -$32.2K ﹤0.01% 2492
2023
Q4
$242K Buy
+136,973
New +$273K ﹤0.01% 2766
2022
Q4
Sell
-43,378
Closed -$84K 3092
2022
Q3
$84K Sell
43,378
-24,266
-36% -$88.1K ﹤0.01% 2253
2022
Q2
$252K Sell
67,644
-114,264
-63% -$453K ﹤0.01% 2084
2022
Q1
$1.19M Buy
181,908
+112,679
+163% +$842K ﹤0.01% 1634
2021
Q4
$807K Buy
+69,229
New +$1.04M ﹤0.01% 2755

Other funds holding TSHA